• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Engelhard Corporation

Engelhard Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company

    BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company

  2. PerfectServe to Share Vision for Future of Secure Clinician Communications at Key Healthcare Conferences

    PerfectServe to Share Vision for Future of Secure Clinician Communications at Key Healthcare Conferences

  3. Kaufman & Broad Announces the Closing of the Refinancing of Its Syndicated Bank Debt (“Senior Debt”)

    Kaufman & Broad Announces the Closing of the Refinancing of Its Syndicated Bank Debt (“Senior Debt”)

  4. Ecopetrol continues to grow in the deepwater U.S. Gulf of Mexico

    Ecopetrol continues to grow in the deepwater U.S. Gulf of Mexico

  5. Needed: More Bailouts

    This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...

  6. Dividend approved by the Shareholders' Meeting of 2014

    Dividend approved by the Shareholders' Meeting of 2014

  7. Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT® (vintafolide) and Companion Imaging Agents FOLCEPRI® (etarfolatide) and NEOCEPRI® (Intravenous (IV) folic acid) in Patients ...

    Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT® (vintafolide) and Companion Imaging Agents FOLCEPRI® (etarfolatide) and NEOCEPRI® (Intravenous (IV) folic acid) in Patients with Platinum-Resistant ...

  8. Transgene Successfully Completes Rights Issue and Private Placement

    Transgene Successfully Completes Rights Issue and Private Placement

  9. Our Outlook for the Credit Markets

    The corporate bond market will probably struggle to return much above break-even in 2014.

  10. Developed Europe: Regional Economic Review – 3Q 2013

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.